FAQ/Help |
Calendar |
Search |
Today's Posts |
02-26-2015, 01:44 PM | #1 | ||
|
|||
Member
|
Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models
http://brain.oxfordjournals.org/cgi/...awv034v1?rss=1 |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease | Parkinson's Disease | |||
High Dose Ketamine Outpatient Treatment | Reflex Sympathetic Dystrophy (RSD and CRPS) | |||
Only one dose of Sinemet in a.m. needed? Opportunity to test alt. treatment in p.m.? | Parkinson's Disease | |||
low dose ketamine treatment | Reflex Sympathetic Dystrophy (RSD and CRPS) | |||
Has anybody with SM heard of treatment with Low Dose Naltrexone | Arnold Chiari Malformation & Syringomyelia |